Skip to content
Home/Companies/Biotech/Sim&Cure
SI

Sim&Cure

Biotech·France·Active·7yr hold

Sim&Cure is a life sciences company, headquartered in France.

Entry
2019
Hold
7yr
Status
Active
Est. EV
–

Who owns Sim&Cure?

Sim&Cure is currently owned by Elaia Partners through Elaia Delta Fund (2017 vintage), since 2019.

Hand-verified · updated 2026-04-21

Elaia Partners
Investor
Elaia Partners
Elaia Delta Fund · 2017 · VC

Key facts

HQFrance
SectorLife Sciences

More from Elaia Delta Fund

Other portfolio companies in the same fund.

Cien
Active
SoftwareSpain· 2019
Eikosim
Active
Data & AnalyticsFrance· 2019
Heuritech
Exited 2024
SoftwareSpain· 2019
to
Hyperlex
Exited 2022
SoftwareFrance· 2019
to
Lybero
Exited 2024
CybersecurityFrance· 2019
Mirakl
Active
SoftwareFrance· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings